Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val R Adams

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Anticancer Research|August 5, 2010
Anticancer activity of novel unnatural synthetic isoprenoidsVal R Adams, David L Deremer, Bojana Stevich, et al.
Investigational New Drugs|November 6, 2004
Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjectsAimee K Bence, Eric B Anderson, Maqbool A Halepota, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Anticancer Research|August 5, 2010
Anticancer activity of novel unnatural synthetic isoprenoidsVal R Adams, David L Deremer, Bojana Stevich, et al.
Investigational New Drugs|November 6, 2004
Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjectsAimee K Bence, Eric B Anderson, Maqbool A Halepota, et al.
Pageof 4